OSUR: Summary for OraSure Technologies, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 1:32am EST - Canadian Markets open in 7 hours and 58 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

OraSure Technologies Inc. (OSUR)

On Feb 9: 4.85 USD

0.06 (1.22%)

MORE ON OSUR

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

OraSure Technologies, Inc. (NasdaqNM:OSUR) Delayed quote data

After Hours: 4.90

0.05 (1.03%) as of 4:42pm EST on 02/09/10

Last Trade:	4.85 USD
Trade Time:	Feb 9
Change:	0.06 (1.22%)
Prev Close:	4.91
Open:	4.95
Bid:	4.18 x 100
Ask:	5.74 x 100
1y Target Est:	12.75

Day's Range:	4.82 - 5.00
52wk Range:	2.20 - 5.51
Volume:	87,382
Avg Vol (3m):	244,405
Market Cap:	222.70M
P/E (ttm):	64.67
EPS (ttm):	0.08
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add OSUR to Portfolio

Download Data

HEADLINES

•	OraSure gets key EU approval for hepatitis C test
	AP (Tue, Dec 15)

•	OraSure settles HIV test patent lawsuit
	AP (Thu, Nov 19)

•	ORASURE TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Fi
	EDGAR Online (Thu, Nov 19)

•	[video] Trading Higher in a Down Market
	at TheStreet.com (Tue, Nov 17)

•	OraSure Tech upgraded by Needham
	Briefing.com (Tue, Nov 17)

•	ORASURE TECHNOLOGIES INC Financials
	EDGAR Online Financials (Tue, Nov 10)

•	ORASURE TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Thu, Nov 5)

•	ORASURE TECHNOLOGIES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
	EDGAR Online (Wed, Nov 4)

•	OraSure Technologies, Inc. Earnings Call scheduled for 5:00 pm ET today
	CCBN (Wed, Nov 4)

•	5-Star Stocks on the Upswing
	at Motley Fool (Mon, Nov 2)

More Headlines for OSUR...

ANALYST

EPS Est (next year) (Dec-07) :	N/A
EPS Est (in 2 years) (Dec-08) :	N/A
Avg Rec (current)*:	1.8
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

OraSure Technologies, Inc. engages in the development, manufacture, marketing, and sale of oral fluid specimen collection devices. Its principal products include OraQuick ADVANCE HIV-1/2, a point-of-care test for antibodies to the human immunodefi...

Full Company Profile

Add to Portfolio

Email to a Friend

•